+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Generic Drugs - Global Market Trajectory & Analytics

  • ID: 5309456
  • Report
  • April 2021
  • Region: Global
  • 285 pages
  • Global Industry Analysts, Inc
Global Generic Drugs Market to Reach $535.5 Billion by 2027

Amid the COVID-19 crisis, the global market for Generic Drugs estimated at US$286 Billion in the year 2020, is projected to reach a revised size of US$535.5 Billion by 2027, growing at a CAGR of 9.4% over the period 2020-2027. Pure Generic Drugs, one of the segments analyzed in the report, is projected to record 9.1% CAGR and reach US$353.2 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Branded Generic Drugs segment is readjusted to a revised 9.9% CAGR for the next 7-year period.

The U.S. Market is Estimated at $77.3 Billion, While China is Forecast to Grow at 12.5% CAGR

The Generic Drugs market in the U.S. is estimated at US$77.3 Billion in the year 2020. China, the world's second largest economy, is forecast to reach a projected market size of US$112.2 Billion by the year 2027 trailing a CAGR of 12.4% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.4% and 8% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 7.3% CAGR.

Select Competitors (Total 42 Featured):
  • Fresenius Kabi AG
  • Mylan Pharmaceuticals, Inc.
  • Novartis AG
  • Pfizer, Inc.
  • Teva Pharmaceutical Industries Ltd.
Note: Product cover images may vary from those shown
I. METHODOLOGY

II. EXECUTIVE SUMMARY
  • Influencer Market Insights
  • Impact of Covid-19 and a Looming Global Recession
III. MARKET ANALYSIS

IV. COMPETITION
  • Total Companies Profiled: 42
Note: Product cover images may vary from those shown
Adroll
adroll